Compare NVRI & STLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVRI | STLN |
|---|---|---|
| Founded | 1853 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Nursing Services |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 582.1M | 628.8M |
| IPO Year | 2026 | 2020 |
| Metric | NVRI | STLN |
|---|---|---|
| Price | $19.94 | $6.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $28.67 | $9.40 |
| AVG Volume (30 Days) | 244.7K | ★ 1.1M |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | ★ 77.20% | N/A |
| EPS Growth | N/A | ★ 23.94 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $502,729,000.00 |
| Revenue This Year | N/A | $32.28 |
| Revenue Next Year | N/A | $32.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.79 |
| 52 Week Low | $11.15 | $5.76 |
| 52 Week High | $24.20 | $7.13 |
| Indicator | NVRI | STLN |
|---|---|---|
| Relative Strength Index (RSI) | 47.43 | 50.26 |
| Support Level | $18.65 | $6.04 |
| Resistance Level | $20.65 | $6.98 |
| Average True Range (ATR) | 0.68 | 0.33 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 59.66 | 48.00 |
Enviri Corp provides environmental and operational solutions to the metal and rail industries. It is based in Philadelphia, Pennsylvania, and operates in more than 30 countries. The company leverages industrial expertise to help customers improve operational performance, recover value from byproducts, enhance sustainability, and maintain critical infrastructure. Its divisions are Harsco Environmental and Harsco Rail, which combine deep operational capabilities with technologies and world-wide scale to deliver long-term value for customers, communities, and shareholders.
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.